Related references
Note: Only part of the references are listed.The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA
Davide Rossi et al.
HEMATOLOGICAL ONCOLOGY (2020)
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright et al.
CANCER CELL (2020)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
Kazuyuki Shimada et al.
LANCET ONCOLOGY (2020)
Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
Keisuke Kataoka et al.
LEUKEMIA (2019)
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States
Marcus Geer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma
Anne M. R. Schrader et al.
BLOOD (2018)
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Yasuhito Suehara et al.
HAEMATOLOGICA (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Yasuhito Suehara et al.
HAEMATOLOGICA (2018)
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing
Sylvain Mareschal et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database
Devalkumar J. Rajyaguru et al.
LEUKEMIA & LYMPHOMA (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Bjoern Chapuy et al.
BLOOD (2016)
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
T. Nakamura et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Genomic characterization of primary central nervous system lymphoma
Kazutaka Fukumura et al.
ACTA NEUROPATHOLOGICA (2016)
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas
Konstantinos Georgiou et al.
BLOOD (2016)
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes
Yasuhiro Suzuki et al.
CANCER SCIENCE (2016)
Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma
K. Shimada et al.
LEUKEMIA (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
Integrated molecular analysis of adult T cell leukemia/lymphoma
Keisuke Kataoka et al.
NATURE GENETICS (2015)
A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures
Yuichi Shiraishi et al.
PLOS GENETICS (2015)
High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma
W. Kraan et al.
LEUKEMIA (2014)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CELL (2013)
Regulation of AID, the B-cell genome mutator
Celia Keim et al.
GENES & DEVELOPMENT (2013)
Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome
Chisako Iriyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma
Andres J. M. Ferreri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan
Kazuyuki Shimada et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Intravascular large B-cell lymphoma (IVLBCL): a chnicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5
Takuhei Murase et al.
BLOOD (2007)
Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
AJM Ferreri et al.
BRITISH JOURNAL OF CANCER (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Share Paper
